Why AbbVie Could Join the M&A Mania Soon Post author:Sam Post published:January 30, 2018 Post category:BioPharma The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace You Might Also Like Amgen to Build New $300M Facility After Tax Changes February 1, 2018 Medtronic Confirms Recall of Its StrataMR Adjustable Valves and Shunts April 6, 2017 Novartis AG Boss Updates Q2 Financials and Reaffirms M&A Strategy July 18, 2017